CARDIOFACIOCUTANEOUS SYNDROME (CFCS) IN THE LIGHT OF CONTEMPORARY RESEARCH - A REVIEW OF THE LITERATURE
Authors:
- Patrycja WalkiewiczPWPatrycja Walkiewicz
- Anna RakoczyARAnna Rakoczy
- Gabriela PrucnalGPGabriela Prucnal
- Jowita FrydrychJFJowita Frydrych
- Karolina OchyraKOKarolina Ochyra
- Karolina RybaKRKarolina Ryba
- Katarzyna ZnamirowskaKZKatarzyna Znamirowska
- Klaudia ZacherKZKlaudia Zacher
- Kornelia PudłoKPKornelia Pudło
- Martyna BukałaMBMartyna Bukała
Open Access
- 18 December 2025
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
Abstract
The term RASopathies was introduced to describe a group of genetic syndromes that share similar phenotypic features and a common molecular basis. RASopathies are among the most numerous groups of recognized congenital developmental disorders. These syndromes have variable clinical courses, and the phenotypic features observed in newborns may differ from those seen in later stages of life - childhood, adolescence, or adulthood - which significantly complicates accurate clinical diagnosis. The underlying cause of these disorders involves mutations in genes encoding proteins associated with the Ras/MAPK (mitogen-activated protein kinase) signaling pathway. Cardiofaciocutaneous syndrome (CFCS) is a representative RASopathy, clinically defined by distinctive craniofacial dysmorphism, congenital heart defects, dermatological anomalies, postnatal growth retardation, and varying degrees of intellectual disability. Recent advances in molecular genetics have facilitated, at least to some extent, the differential diagnosis of CFCS, thereby improving diagnostic accuracy. Lifelong, multidisciplinary medical management is essential for both pediatric and adult patients, necessitating coordinated care involving specialists from various medical fields. This article focuses on the molecular pathogensis, clinical features, prenatal findings and recommended evaluations following initial diagnosis. Materials: We conducted a review and analysis of the literature available in the PubMed database, using keywords.Keywords
This publication has 20 references indexed in Scilit:
- Obstetrical and neonatal outcomes of cardio‐facio‐cutaneous syndrome: Prenatal consequences of Ras/MAPK dysregulationAmerican Journal of Medical Genetics Part A, 2022
- Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort studyGenetics in Medicine, 2022
- The RASopathies: from pathogenetics to therapeuticsDisease Models & Mechanisms, 2022
- Social behavior in RASopathies and idiopathic autismJournal of Neurodevelopmental Disorders, 2022
- When to test fetuses for RASopathies? Proposition from a systematic analysis of 352 multicenter cases and a postnatal cohortGenetics in Medicine, 2021
- Musculo-skeletal phenotype of Costello syndrome and cardio-facio-cutaneous syndrome: insights on the functional assessment statusOrphanet Journal of Rare Diseases, 2021
- RAS pathway influences the number of melanocytic nevi in cardiofaciocutaneous and Costello syndromesJournal of the American Academy of Dermatology, 2020
- Cardio‐facio‐cutaneous syndrome: Does genotype predict phenotype?American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011
- The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulationCurrent Opinion in Genetics & Development, 2009
- The Ras/Raf/MAPK PathwayJournal of Thoracic Oncology, 2006